Ryan Weispfenning | Vice President and Head, Investor Relations |
Geoff Martha | Chairman and Chief Executive Officer |
Karen Parkhill | Chief Financial Officer |
Brad Welnick | Investor Relations |
Que Dallara | Executive Vice President and President, Diabetes Operating Unit |
Sean Salmon | Executive Vice President and President, Cardiovascular Portfolio |
Brett Wall | Executive Vice President and President, Neuroscience Portfolio |
Bob White | Executive Vice President and President, Medical Surgical Portfolio |
Robbie Marcus | JPMorgan |
Travis Steed | Bank of America |
Vijay Kumar | Evercore ISI |
Larry Biegelsen | Wells Fargo |
Matt O’Brien | Piper Sandler |
Josh Jennings | Cowen & Company |
Matt O’Brien | Piper Sandler |
Matt Taylor | Jefferies |
Pito Chickering | Deutsche Bank |
Joanne Wuensch | Citi |
Good morning. I am Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations and welcome to snowing Minneapolis. I appreciate that you are joining us today for Medtronic’s Fiscal Year 2023 Second Quarter Earnings Video Webcast.
Before we go inside to hear our prepared remarks, I will share a few details about today’s webcast.
Joining me are Geoff Martha, Medtronic Chairman and Chief Executive Officer and Karen Parkhill, Medtronic Chief Financial Officer.